Vanguard Group Inc Actinium Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,625,000 shares of ATNM stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,625,000

Previous 1,479,210 9.86%

Holding current value

$2.1 Million

Previous $10.9 Million 72.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.72 - $8.0 $250,758 - $1.17 Million	145,790 Added 9.86%	1,625,000 $3.06 Million
Q2 2024 Aug 13, 2024	BUY	$6.56 - $9.89 $215,719 - $325,222	32,884 Added 2.27%	1,479,210 $10.9 Million
Q1 2024 May 10, 2024	BUY	$5.0 - $9.2 $410,565 - $755,439	82,113 Added 6.02%	1,446,326 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$4.02 - $6.08 $91,109 - $137,797	22,664 Added 1.69%	1,364,213 $6.93 Million
Q3 2023 Nov 14, 2023	BUY	$5.91 - $7.37 $42,947 - $53,557	7,267 Added 0.54%	1,341,549 $7.94 Million
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.39 $360,231 - $473,086	50,382 Added 3.92%	1,334,282 $9.9 Million
Q1 2023 May 15, 2023	BUY	$8.51 - $14.26 $1.42 Million - $2.38 Million	166,849 Added 14.94%	1,283,900 $12.1 Million
Q4 2022 Feb 10, 2023	BUY	$7.05 - $14.41 $339,133 - $693,178	48,104 Added 4.5%	1,117,051 $11.9 Million
Q2 2022 Aug 12, 2022	BUY	$4.71 - $7.11 $989,618 - $1.49 Million	210,110 Added 24.46%	1,068,947 $5.14 Million
Q1 2022 May 13, 2022	SELL	$4.57 - $6.4 $30,856 - $43,212	-6,752 Reduced 0.78%	858,837 $4.39 Million
Q4 2021 Feb 14, 2022	SELL	$6.01 - $8.8 $6,863 - $10,049	-1,142 Reduced 0.13%	865,589 $5.2 Million
Q3 2021 Nov 12, 2021	BUY	$5.76 - $9.67 $271,232 - $455,350	47,089 Added 5.75%	866,731 $7.68 Million
Q2 2021 Aug 13, 2021	BUY	$7.01 - $8.63 $5.75 Million - $7.07 Million	819,642 New	819,642 $6.48 Million

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.31M

Call Options Held

65.2K

Put Options Held

21.7K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $32.5M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Actinium Pharmaceuticals, Inc. Transaction History